Investor mix
3 investors on record; lead investors include New Enterprise Associates, Takeda Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Dimer conjugates gastrointestinal disorders, pain and diseases featuring amyloids.
3 investors on record; lead investors include New Enterprise Associates, Takeda Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |